Delivery Order SPE2DX22D0049-SPE2D825FA9KM
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,367.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $181,081.98 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract under which AmerisourceBergen will supply pharmaceutical products and medical supplies to support federal military and healthcare operations. The...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $50,107.12 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger federal contract vehicle. The work is being performed at the company's corporate office in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $13,788.50 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,532.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $22,525.30 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on June 14, 2025, with completion expected by June 16, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order for pharmaceutical and medical supply products to support federal military and healthcare operations. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $13,413.71 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with ultimate completion by August 5, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance at the contractor's facility in Conshohocken, Pennsylvania. As a child contract under a larger indefinite delivery vehicle, this award reflects AmerisourceBergen's role...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $36,078.78 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award under AmerisourceBergen's broader contract vehicle with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $138,809.60 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and represents a child contract under AmerisourceBergen's larger federal contract vehicle. The work will be performed at the company's corporate office in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $31,361.72 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D825FA9KMDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $35,386.06 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, awarded without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's broader contract vehicle with the Defense Logistics Agency. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a primary pharmaceutical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems globally, including products across multiple therapeutic domains such as diabetes medications, neurological treatments, pain management pharmaceuticals, vaccines, and specialized medical devices. The company's role within this IDC vehicle demonstrates its strategic importance as a critical supplier for the Defense Health Agency and broader military medical logistics operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.4k | 7/28/25 |